Intervention: orelabrutinib combined with the Pola-R-CHP regimen
Found 4 matching trials
Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL)
PHASE2
This study is a prospective, open-label, multicenter study in previously un...
Status
Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University